KZRKezar Life Sciences, Inc.

Nasdaq kezarlifesciences.com


$ 0.66 $ -0.02 (-3.3 %)    

Monday, 17-Jun-2024 12:54:28 EDT
QQQ $ 483.88 $ 3.92 (0.82 %)
DIA $ 387.59 $ 1.13 (0.29 %)
SPY $ 546.29 $ 4.21 (0.78 %)
TLT $ 93.61 $ -0.25 (-0.27 %)
GLD $ 214.29 $ -0.59 (-0.27 %)
$ 0.6825
$ 0.69
$ 0.00 x 0
$ 0.66 x 100
$ 0.66 - $ 0.69
$ 0.65 - $ 2.69
205,605
na
49.69M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 kezar-life-sciences-q1-eps-030-beats-033-estimate

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 kezar-life-sciences-q4-eps-044-misses-038-estimate

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of ...

 reported-late-monday-everest-medicines-and-kezar-life-sciences-received-ind-approval-from-chinas-nmpa-for-the-palizade-trial-in-lupus-nephritis

Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (NASDAQ:KZR) announced today that the Center for Drug Evaluation...

 as-oversupply-deflates-lithium-bubble-ipo-market-keeps-in-high-spirits

Lithium market facing persistent turmoil as spot prices decline for more than a year. But asset management firm Janus Henderson...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 wells-fargo-maintains-equal-weight-on-kezar-life-sciences-lowers-price-target-to-2

Wells Fargo analyst Derek Archila maintains Kezar Life Sciences (NASDAQ:KZR) with a Equal-Weight and lowers the price target...

 kezar-life-sciences-q3-eps-032-beats-035-estimate-sales-700k

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-kezar-life-sciences-maintains-20-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Buy and maintains $20 ...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 369 companies hit new 52-week lows.

 jonestrading-downgrades-kezar-life-sciences-to-hold

JonesTrading analyst Catherine Novack downgrades Kezar Life Sciences (NASDAQ:KZR) from Buy to Hold.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.